GENIXUS announced the accelerated development and launch* of the latest product within their KinetiX syringe platform: Rocuronium Bromide Injection. The decision comes in response to the recent natural disaster impacting Pfizer's manufacturing site in Rocky Mount, NC, and the expected impact on the sterile injectables market as a result of this event.
"Our thoughts are with the individuals impacted by the natural disaster at Rocky Mount,” CEO of GENIXUS, Kendall Foster, stated. “We understand the gravity of the situation and the critical need for medications in the market. GENIXUS is committed to taking swift action to address these challenges and ensure patients have access to the medications they require."
KinetiX Rocuronium Bromide Injection possesses several key attributes inherent in the KinetiX platform:
- Intuitive labeling and color-coded plunger rod to support rapid identification
- Auto-dispensing cabinet (ADC) ready to keep product proximal to delivery site
- RFID-enabled with KitCheck®, the latest technology in kit and tray management
- 5mL and 10mL RTA syringes offer flexibility to minimize waste
- Durable polymer syringe is clear and eliminates risks of glass
- 3-month beyond use date (BUD) at launch
- Stability enhancements will be shared as program data become available
GENIXUS' Chief Commercial Officer (CCO), Seth Coombs, emphasized the company's determination to accelerate the launch of Rocuronium Bromide Injection to address the ongoing, and expected worsening, of shortages in the US market. "GENIXUS is fully dedicated to doing our part to support patient care during this critical time. Our decision to fast-track the development and market entry of Rocuronium Bromide Injection reflects our commitment to supporting the availability of essential medications for patients across the country."
KinetiX Rocuronium Bromide Injection is the 2nd product in the syringe platform following GENIXUS’ launch of repackaged Propofol 10mL & 20mL RTA syringes earlier this year.**
Subscribe to our e-Newsletters
Stay up to date with the latest news, articles, and events. Plus, get special
offers from Pharmaceutical Outsourcing – all delivered right to your inbox! Sign up now!